2020, Number 1-2
Rev Sanid Milit Mex 2020; 74 (1-2)
Deficiency of vitamin D is a risk factor of mortality in patients with COVID-19
Rodríguez TA, Montelongo MEA, Martínez-Cuazitl A, Puente NAV, Reyes PRA
Language: Spanish
References: 27
Page:
PDF size: 293.30 Kb.
ABSTRACT
Introduction: At this moment COVID-19 disease has no specific treatment and there is no vaccine available. This disease has an elevated morbidity-mortality not only in Mexico but worldwide, and it is the reason why it’s essential to study factors that could modulate the course of the disease; the role of vitamin D seems to have a fundamental role in immunity when we talk about respiratory infections.
Objective: Determine the association between vitamin D levels and mortality in hospitalized patients with COVID-19 at the Hospital Central Militar México.
Material and methods: This study included 172 patients diagnosed with COVID-19 whom serum levels of vitamin 25-(OH)- D were determined. Considering as a case the patients who died from COVID-19 and control patients who survived.
Results: Vitamin 25-(OH)-D serum levels in hospitlized patients with COVID-19 were 16.54 ± 7.22 ng/mL. The 95.92% presented vitamin D levels below the ideal range. Patients with vitamin D serum levels bellow 8 ng/mL had 3.68 higher risk of dying from COVID-19.
Conclusion: Patients with COVID-19 who require hospitalization were deficient in vitamin D and their serum levels were bellow 8 ng/mL. This is considered a risk factor and therefore increases mortality in the disease caused by COVID-19, reason enough to take several actions such as oral suplementation in order to improve vitamin D serum levels.
REFERENCES
Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, a worldwide public health emergency [published online ahead of print, 2020 Mar 20]. COVID-19, una emergencia de salud pública mundial [published online ahead of print, 2020 Mar 20]. Rev Clin Esp. 2020;S0014-2565(20)30092-8. doi:10.1016/j.rce.2020.03.001
Grant, WB; Lahore, H .; McDonnell, SL; Baggerly, CA; Francés, CB; Aliano, JL; Bhattoa, HP Evidencia de que la suplementación con vitamina D podría reducir el riesgo de influenza e infecciones y muertes por COVID-19. Nutrientes 2020 , 12 , 988
Study and fight Coronavirus with research tools from PromoCell. PromoCell. 2020. Available in: https://www.promocell.com/news/news-announcement/study-and-fight-coronavirus-with-research-tools-from-promocell/
Kechichian E, Ezzedine K. Vitamin D and the skin: an update for dermatologists. Am J Clin Dermatol. 2018; 19 (2): 223-235. Available in: https://doi.org/10.1007/s40257-017-0323-8.
Hossein-Nezhad A, Holick M. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013; 88 (7): 720-755. Available in: https://doi.org/10.1016/j.mayocp.2013.05.011.
Holick MF. Medical progress: vitamin D deficiency. N Engl J Med. 2007; 357 (3): 266-281. Available in: https://doi.org/10.1056/NEJMra070553
Varsavskya M, Rozas P, Becerra A, Luque I, Quesada JM, Ávila V et al. Recomendaciones de vitamina D para la población general. Endocrinol Diabetes Nutr. 2017; 64: 7-14. Disponible en; https://doi.org/10.1016/j.endinu.2016.11.002.
Grant, WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020; 12 (4): 988. Available in: https://doi.org/10.3390/nu12040988
Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality [published online ahead of print, 2020 May 6]. Aging Clin Exp Res. 2020; 1-4. Available in: https://doi.org/10.21203/rs.3.rs-21211/v1
Teymoori-Rad M, Shokri F, Salimi V, Marashi SM. The interplay between vitamin D and viral infections. Rev Med Virol. 2019; 29 (2): e2032. Available in: https://doi.org/10.1002/rmv.2032.
Cui C, Xu P, Li G, Qiao Y, Han W, Geng C et al Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system. Redox Biol. 2019; 26: 101295. Available in: https://doi.org/10.1016/j.redox.2019.101295
Soler MJ, Lloveras J, Batlle D. Enzima conversiva de la angiotensina 2 y su papel emergente en la regulación del sistema renina-angiotensina. Medicina Clínica. 2008; 131 (6): 230-236. Disponible en: https://doi.org/10.1157/13124619
Tikellis C, Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012; 2012: 256294. Available in: https://doi.org/10.1155/2012/256294
Información General. Covid-19 México. 2020. Disponible en: https://coronavirus.gob.mx/datos/
Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020; 395 (10229): 1054-1062.
Lips P, Cashman K, Lamberg-Allardt C, Bischoff-Ferrari H, Obermayer-Pietsch B, Bianchi ML et al. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society. Eur J Endocrinol. 2019; 180 (4): 23-54. Available in: https://doi.org/10.1530/EJE-18-0736
Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134(6):1129-1140. doi:10.1017/S0950268806007175
Spiro A, Buttriss JL. Vitamin D: an overview of vitamin D status and intake in Europe. Nutr Bull. 2014; 39 (4): 322-350. Available in: https://doi.org/10.1111/nbu.12108.
Sowah D, Fan X, Dennett L, Hagtvedt R, Straube S. Vitamin D levels and deficiency with different occupations: a systematic review. BMC Public Health. 2017; 17 (1): 519-544. Available in: https://doi.org/10.1186/s12889-017-4436-z.
Amrein K, Scherkl M, Hoffmann M, Neuwersch S, Köstenberger M, Tmava A et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020; 1-16. Available in: https://doi.org/10.1038/s41430-020-0558-y.
Ianevski A, Zusinaite E, Shtaida N, Kallio-Kokko H, Valkonen M, Kantele A et al. Low temperature and low UV indexes correlated with peaks of influenza virus activity in Northern Europe during 2010-2018. Viruses. 2019; 11 (3): 207-216. Available in: https://doi.org/10.3390/v11030207.
Richardson S, Hirsch JS, Narasimhan M et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area [published online ahead of print, 2020 Apr 22]. JAMA. 2020; e206775. doi: 10.1001/jama.2020.6775.
Raharusun P, Priambada S, Budiarti C, Agung E, Budi C. Patterns of COVID-19 Mortality and Vitamin D: An Indonesian Study. 2020.
Rhodes JM, Subramanian S, Laird E, Kenny RA. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment Pharmacol Ther. 2020; 51 (12): 1434-1437. Available in: https://doi.org/10.1111/apt.15777
Marik PE, Kory P, Varon J. Does vitamin D status impact mortality from SARS-CoV-2 infection? [published online ahead of print, 2020 Apr 29]. Med Drug Discov. 2020; 100041. doi: 10.1016/j.medidd.2020.100041.
Rhodes LE, Webb AR, Fraser HI, Kift R, Durkin MT, Allan D et al. Rhodes LE, Webb AR, Fraser HI, et al. Recommended summer sunlight exposure levels can produce sufficient (> or =20 ng ml(-1)) but not the proposed optimal (> or =32 ng ml(-1)) 25(OH)D levels at UK latitudes. J Invest Dermatol. 2010; 130 (5): 1411-1418. Available in: https://doi.org/10.1038/jid.2009.417
Khan QJ, Fabian CJ. How I treat vitamin d deficiency. J Oncol Pract. 2010; 6 (2): 97-101.